Literature DB >> 27117441

Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy.

R Christopher Doiron1, Victoria Tolls1, Karen Irvine-Bird1, Kerri-Lynn Kelly1, J Curtis Nickel2.   

Abstract

PURPOSE: Identifying Hunner lesions in patients with interstitial cystitis/bladder pain syndrome presents an opportunity for objective classification into Hunner lesion interstitial cystitis/bladder pain syndrome (classic interstitial cystitis) and nonHunner lesion bladder pain syndrome. While currently the former diagnosis requires cystoscopy, limited data suggest that these subtypes can be distinguished without endoscopy based on the degree of bladder focused centricity and the infrequent association with generalized pain conditions.
MATERIALS AND METHODS: Patients in a prospective, single center database of interstitial cystitis/bladder pain syndrome who had documented cystoscopic findings were categorized with Hunner lesion interstitial cystitis/bladder pain syndrome or nonHunner lesion bladder pain syndrome. Demographics, pain and symptom scores, voiding symptoms, irritable bowel syndrome and clinical UPOINT (urinary, psychosocial, organ specific, infection, neurological and tenderness) scoring were comparatively analyzed.
RESULTS: We reviewed the records of 469 patients, including 359 with documented local anesthetic cystoscopic findings, 44 (12.3%) with Hunner lesion interstitial cystitis/bladder pain syndrome and 315 (87.7%) with nonHunner bladder pain syndrome. Patients with Hunner lesions were older (p = 0.004) and had greater urinary frequency (p = 0.013), more nocturia (p = 0.0004) and higher ICSI (Interstitial Cystitis Symptom Index) scores (p = 0.017). Hunner lesion prevalence was significantly lower in those younger than 50 years vs those 50 years old or older (7.8% vs 14.9%, p = 0.0095). There was no difference in the number of UPOINT phenotype domains reported, overall UPOINT scores or the prevalence of irritable bowel syndrome between the groups.
CONCLUSIONS: A subtype of interstitial cystitis with Hunner lesions has worse bladder centric symptoms but did not show a distinct bladder centric phenotype. Given the management implications of distinguishing classic interstitial cystitis from nonHunner lesion bladder pain syndrome, we recommend cystoscopy with local anesthesia in patients diagnosed with interstitial cystitis/bladder pain syndrome.
Copyright © 2016 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cystitis, interstitial; cystoscopy; diagnosis; pain; urinary bladder

Mesh:

Year:  2016        PMID: 27117441     DOI: 10.1016/j.juro.2016.04.067

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

Review 1.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

2.  Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.

Authors:  Pedro L Vera; David M Preston; Robert M Moldwin; Deborah R Erickson; Behzad Mowlazadeh; Fei Ma; Dimitrios E Kouzoukas; Katherine L Meyer-Siegler; Magnus Fall
Journal:  Urology       Date:  2018-03-23       Impact factor: 2.649

3.  Comparison of deep phenotyping features of UCPPS with and without Hunner lesion: A MAPP-II Research Network Study.

Authors:  H Henry Lai; Craig Newcomb; Steve Harte; Dina Appleby; A Lenore Ackerman; Jennifer T Anger; J Curtis Nickel; Priyanka Gupta; Larissa V Rodriguez; J Richard Landis; J Quentin Clemens
Journal:  Neurourol Urodyn       Date:  2021-02-19       Impact factor: 2.696

Review 4.  Recent advances in imaging and understanding interstitial cystitis.

Authors:  Pradeep Tyagi; Chan-Hong Moon; Joseph Janicki; Jonathan Kaufman; Michael Chancellor; Naoki Yoshimura; Christopher Chermansky
Journal:  F1000Res       Date:  2018-11-09

5.  Current best practice management of interstitial cystitis/bladder pain syndrome.

Authors:  Esther Han; Laura Nguyen; Larry Sirls; Kenneth Peters
Journal:  Ther Adv Urol       Date:  2018-03-19

6.  Anesthetic Bladder Capacity is a Clinical Biomarker for Interstitial Cystitis/Bladder Pain Syndrome Subtypes.

Authors:  Andre Plair; Robert J Evans; Carl D Langefeld; Catherine A Matthews; Gopal Badlani; Stephen J Walker
Journal:  Urology       Date:  2021-07-22       Impact factor: 2.649

7.  Current Understanding and Future Perspectives of Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Tomohiro Ueda; Philip M Hanno; Ryoichi Saito; Jane M Meijlink; Naoki Yoshimura
Journal:  Int Neurourol J       Date:  2021-06-30       Impact factor: 2.835

8.  Differences in Urodynamic Parameters According to the Presence of a Hunner Lesion in Women With Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Sun Tae Ahn; Hyeong Guk Jeong; Tae Yong Park; Jong Wook Kim; Hong Seok Park; Du Geon Moon; Jeong Gu Lee; Mi Mi Oh
Journal:  Int Neurourol J       Date:  2018-01-31       Impact factor: 2.835

9.  Cystoscopic evaluation and clinical phenotyping in interstitial cystitis/bladder pain syndrome

Authors:  Ömer Acar; Tufan Tarcan
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-11-20

10.  Does cystoscopy method affect the investigation of bladder pain syndrome/interstitial cystitis?

Authors:  Visha K Tailor; Ellen Morris; Alka A Bhide; Ruwan Fernando; Guiseppe A Digesu; Vik Khullar
Journal:  Int Urogynecol J       Date:  2020-09-21       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.